Casdin Capital, LLC

13F Holdings History for BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS)

Symbol: BLFS on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 5.96M shares
Security Ownership: 12.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Casdin Capital, LLC ownership in BIOLIFE SOLUTIONS INC Common Stock, par value $0.001 per share (BLFS)

2025-10-17 - Casdin Capital, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.96M shares of BIOLIFE SOLUTIONS INC Common Stock, par value $0.001 per share (BLFS). This represents 12.4% percent ownership of the company. In their previous filing dated 2025-08-21, Casdin Capital, LLC had reported owning 6.71M shares, indicating a decrease of -11.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Casdin Capital, LLC	12.4%	-11.4%	$152M	5.96M	-750,000	-11.2%	$25.51	13D/A	10/15/2025	17 Oct 2025 20:04:16
Casdin Capital, LLC	14%	-6.67%	$140M	6.71M	-500,000	-6.94%	$20.81	13D/A	8/15/2025	21 Aug 2025 21:35:50
Casdin Capital, LLC	15%	-7.5%	$150M	7.21M	-500,000	-6.49%	$20.81	13D/A	8/11/2025	13 Aug 2025 19:00:45
Casdin Capital, LLC	16.2%	-12.1%	$179M	7.71M	-1,027,994	-11.8%	$23.29	13D/A	6/10/2025	12 Jun 2025 21:10:05
Casdin Capital, LLC	18.5%		$199M	8.74M			$22.79	13D/A	4/7/2025	9 Apr 2025 17:13:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	14.3%	-2.13%	$171M	6.71M	-1,000,000	-13%	$25.51	Q3 2025
6/30/2025	15.1%	-1.96%	$166M	7.71M	-1,000,000	-11.5%	$21.54	Q2 2025
3/31/2025	16.3%		$199M	8.71M			$22.84	Q1 2025
12/31/2024	15.1%		$226M	8.71M			$25.96	Q4 2024
9/30/2024	14.5%		$218M	8.71M			$25.04	Q3 2024
6/30/2024	14.2%		$187M	8.71M			$21.43	Q2 2024
3/31/2024	12%		$162M	8.71M			$18.55	Q1 2024
12/31/2023	14%	+1.69%	$141M	8.71M	+927,165	+11.9%	$16.25	Q4 2023
9/30/2023	11.9%	+0.09%	$107M	7.78M	+58,465	+0.76%	$13.81	Q3 2023
6/30/2023	14.9%	+0.29%	$171M	7.72M	+150,000	+1.98%	$22.10	Q2 2023
3/31/2023	13.6%	+0.01%	$165M	7.57M	+5,243	+0.07%	$21.75	Q1 2023
12/31/2022	10.7%		$138M	7.57M			$18.20	Q4 2022
9/30/2022	11.4%		$172M	7.57M			$22.75	Q3 2022
6/30/2022	8.83%		$104M	7.57M			$13.81	Q2 2022
3/31/2022	7.71%		$172M	7.57M			$22.73	Q1 2022
12/31/2021	7.95%		$282M	7.57M			$37.27	Q4 2021
9/30/2021	7.99%	+0.14%	$320M	7.57M	+126,185	+1.7%	$42.32	Q3 2021
6/30/2021	8.41%		$331M	7.44M			$44.51	Q2 2021
3/31/2021	7.98%		$268M	7.44M			$36.00	Q1 2021
12/31/2020	8.79%	+1.89%	$297M	7.44M	+1,600,000	+27.4%	$39.89	Q4 2020
9/30/2020	7.57%	+1.28%	$169M	5.84M	+990,583	+20.4%	$28.94	Q3 2020
6/30/2020	4.69%	+2.3%	$79.3M	4.85M	+2,380,953	+96.5%	$16.35	Q2 2020
3/31/2020	2.49%		$23.5M	2.47M			$9.50	Q1 2020
12/31/2019	3.67%	+0.06%	$39.9M	2.47M	+40,000	+1.65%	$16.18	Q4 2019
9/30/2019	4.18%		$40.4M	2.43M			$16.63	Q3 2019
6/30/2019	3.69%		$39.4M	2.43M			$16.23	Q2 2019
3/31/2019	4.77%		$43.4M	2.43M			$17.89	Q1 2019
12/31/2018	5%		$29.2M	2.43M			$12.03	Q4 2018
9/30/2018	5.17%	+3.04%	$42.5M	2.43M	+1,428,571	+143%	$17.50	Q3 2018
6/30/2018	1.6%	+1.6%	$11.4M	1M	+1,000,000	NEW	$11.41	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.